“Perhaps a decade away, we may see new treatments for muscular dystrophy and cystic fibrosis. I think the challenges for these diseases. have less to do with the gene-editing technology and more to do with figuring out how to deliver the editing molecules into tissues.”— Jennifer Doudna, newsweek.com